In Depth 13 Oct 2025 Cambridge’s biotech scene: The cornerstone of the UK’s Golden Triangle Home to a well-established hub with strong investment and startup activity, discover what makes Cambridge’s biotech scene so special. October 13, 2025 - 8 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 7 Oct 2025 AKIGAI takes EGFR inhibitors beyond cancer to treat neuropathic pain Discover how AKIGAI’s EGFR inhibitors may redefine neuropathic pain therapy and offer hope for complex regional pain syndrome (CRPS). October 7, 2025 - 9 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 3 Oct 2025 The biggest biotech funding rounds in September 2025 uniQure, Dianthus Therapeutics, and Mineralys Therapeutics bagged the biggest biotech funding rounds overall in September 2025. October 3, 2025 - 5 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 26 Sep 2025 Can biotechnology reduce animal testing in medicine? Animal testing is crucial for measuring the efficacy and safety of new treatments. It is also a step that everyone would like to avoid as much as possible for economic, regulatory, and ethical reasons. But what are the alternatives, and can they really reduce the use of animals in drug development? Before drug developers let […] September 26, 2025 - 14 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 24 Sep 2025 Eli Lilly’s strategy in motion: Beyond diabetes and obesity Delve into a biopharma giant’s strategy, Eli Lilly. This past year, the company secured regulatory milestones and strategic deals. September 24, 2025 - 8 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 10 Sep 2025 When rare diseases are not so rare after all: A closer look at where and why this happens Discover how in some communities around the world, the prevalence of rare diseases is higher due to factors like cousin marriages. September 10, 2025 - 12 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 5 Sep 2025 Closing treatment gaps in yellow fever: are germ-free egg-based vaccines the answer? Germ-free egg-based vaccines could be the answer to curbing yellow fever outbreaks. September 5, 2025 - 7 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 3 Sep 2025 How are biotechs tackling malaria? As a recent approval closes a major therapeutic gap, let’s take a look at some of the latest progress and new treatments against malaria. September 3, 2025 - 13 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 2 Sep 2025 The biggest biotech funding rounds in August 2025 Kriya Therapeutics, Strand Therapeutics, and Minghui Pharmaceutical bagged the biggest biotech funding rounds overall in August 2025. September 2, 2025 - 4 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 1 Sep 2025 Blood Cancer Awareness Month: What biotech holds in store As September marks the beginning of Blood Cancer Awareness Month, delve into what is being developed in the biotech pipelines. September 1, 2025 - 13 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 29 Aug 2025 Can genetically modified crops help us adapt to climate change? Find out whether genetically modified crops can help us adapt to climate change and ensure global food security. August 29, 2025 - 14 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 22 Aug 2025 The Sanofi pipeline in 2025: Is the play-to-win strategy working? Find out what Sanofi has been up to in 2025, especially as it just closed the Opella deal and is now expanding its pipeline. August 22, 2025 - 12 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email